NextCure Inc. Common Stock (NXTC)
Stock · NASDAQ · Health Care
$6.24as of 10/16/2026
Price chart
Active signals
NXTC Signal Track Record
How signals performed across all stocks →What NXTC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 25 | +5.6% | 52% | September 23, 2026 |
| Bollinger Band Breakout | 22 | -10.7% | 32% | August 12, 2026 |
| Bollinger Band Breakdown | 19 | -6.8% | 37% | May 22, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -11.1% | 36% | April 27, 2026 |
| Any 20-session window (baseline) | -3.4% | 42% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NXTC
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 40
- Website
- www.nextcure.com/
Fundamentals
- 1-day range
- $6.59$7.21
- Market cap
- $20.19M
- P/E (trailing)
- —
- P/E (forward)
- -1.17
- EPS (trailing)
- $-10.27
- Dividend yield
- —
- Beta
- 1.29
- Avg. volume
- 235.4K
How NextCure Inc. Common Stock Makes Money
Where the revenue actually goes — FY2020 annual results
Source: 10-K filed Mar 4, 2021 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
NextCure Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- NXTCNextCure Inc. Common Stock$6.24▼ 9.30%Market cap $20.19MP/E —$1.55$15.74
- CLRBCellectar Biosciences Inc. Common Stock$1.14▼ 4.20%Market cap $20.14MP/E —$1.15$5.07
- DAREDare Bioscience Inc. Common Stock$0.725▼ 2.03%Market cap $19.92MP/E —$0.69$3.78
- GRDXGridAI Technologies Corp. Common Stock$4.22▼ 5.38%Market cap $19.91MP/E —$1.87$6.93
- CELUCelularity Inc. Class A Common Stock$1.25▼ 6.02%Market cap $19.77MP/E —$0.5601$2.55
- RKTORocket One Inc. Common Stock$0.507▼ 5.59%Market cap $19.75MP/E —$0.51$2.45
- QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares$2.47▼ 8.86%Market cap $20.67MP/E —$2.85$23.1
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NXTC NextCure Inc. Common Stock | $20.19M | — | $6.24 | ▼ 9.30% | $1.55$15.74 |
| CLRB Cellectar Biosciences Inc. Common Stock | $20.14M | — | $1.14 | ▼ 4.20% | $1.15$5.07 |
| DARE Dare Bioscience Inc. Common Stock | $19.92M | — | $0.725 | ▼ 2.03% | $0.69$3.78 |
| GRDX GridAI Technologies Corp. Common Stock | $19.91M | — | $4.22 | ▼ 5.38% | $1.87$6.93 |
| CELU Celularity Inc. Class A Common Stock | $19.77M | — | $1.25 | ▼ 6.02% | $0.5601$2.55 |
| RKTO Rocket One Inc. Common Stock | $19.75M | — | $0.507 | ▼ 5.59% | $0.51$2.45 |
| QNTM Quantum Biopharma Ltd. Class B Subordinate Voting Shares | $20.67M | — | $2.47 | ▼ 8.86% | $2.85$23.1 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/2/2026
- What's going on in today's after hours sessionChartMill · 10/1/2026
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · 10/1/2026
Insider Activity
Insider Actions →- Simcere Zaiming, Inc. · August 10, 2026 · Sale30.0K @ $6.16
- ADAR1 Capital Management, LLC · July 31, 2026 · Buy3.3K @ $4.98
- ADAR1 Capital Management, LLC · July 31, 2026 · Buy8.0K @ $4.8
- ADAR1 Capital Management, LLC · July 31, 2026 · Buy25.0K @ $4.98
- ADAR1 Capital Management, LLC · July 30, 2026 · Buy77.8K @ $4.96
- ADAR1 Capital Management, LLC · July 30, 2026 · Buy100.0K @ $4.9
- ADAR1 Capital Management, LLC · July 30, 2026 · Buy25.0K @ $4.81
- ADAR1 Capital Management, LLC · July 30, 2026 · Buy20.0K @ $5
- ADAR1 Capital Management, LLC · July 30, 2026 · Buy50.0K @ $4.97
- ADAR1 Capital Management, LLC · July 29, 2026 · Buy1.6K @ $5
- ADAR1 Capital Management, LLC · July 29, 2026 · Buy1.8K @ $5
- ADAR1 Capital Management, LLC · July 28, 2026 · Buy6.4K @ $4.95
- ADAR1 Capital Management, LLC · July 27, 2026 · Buy7.8K @ $5
- Borgman Anne Elizabeth · June 18, 2026 · Grant2.3K
- Ellen Feigal · June 18, 2026 · Grant2.3K
Institutional Ownership
March 31, 2026
- Total shares held
- 2.01M
- Total value held
- $21.06M
- Institutional holders
- 24
- Unknown265.0K
- Unknown241.8K
- Unknown238.3K
- Unknown222.7K
- Unknown176.1K
- Unknown153.4K
- Unknown141.2K
- Unknown117.4K
- Unknown115.5K
- Unknown69.6K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
NXTC noted in after‑hours market coverage
NextCure Inc. appeared in after‑hours market reports today. The stock was highlighted in a ChartMill after‑hours session overview and listed among twelve health‑care stocks that moved in Thursday’s after‑market trading. The coverage suggests recent investor attention, while the stock remains near its recent support level.
NXTC noted in after‑hours market coverage. NextCure Inc. appeared in after‑hours market reports today. The stock was highlighted in a ChartMill after‑hours session overview and listed among twelve health‑care stocks that moved in Thursday’s after‑market trading. The coverage suggests recent investor attention, while the stock remains near its recent support level.